Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
10/2003
10/28/2003US6638941 Conformationallly constrained peptidomimetics as β-turn templates and modulators of SH3 domains
10/28/2003US6638912 Peptide compositions mimicking TGF-β activity
10/28/2003US6638911 Modulating agents comprise one or more of a peptide sequence that is at least 50% identical to a desmosomal cadherin CAR sequence; a non-peptide mimetic of a desmosomal cadherin CAR sequence; a substance, such as an antibody or antigen binding
10/28/2003US6638910 Compositions and methods for controlling plant pests
10/28/2003US6638531 Peptide antibiotics for resistant bacteria; fungicides
10/28/2003US6638512 Method for treating subjects by using BAGE tumor rejection antigen precursors or tumor rejection antigens
10/28/2003US6638511 Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis
10/28/2003US6638505 For prevention of influenza virus binding to cells, therapy of schizophrenia and diagnosing chronic viral disease associated with development of cancer
10/28/2003CA2058020C Short peptides with insulin activity
10/23/2003WO2003087824A2 Charge-balanced chemoselective linkers
10/23/2003WO2003087400A1 Methods and reagents for assaying protein kinase activity
10/23/2003WO2003087161A1 Modified factor viii
10/23/2003WO2003087138A2 Methods for identifying polypeptide factors interacting with rna
10/23/2003WO2003087137A2 New therapeutic uses of tri-, tetra-, penta-, and polypeptides
10/23/2003WO2003087126A2 Heteroclitic analogs and related methods
10/23/2003WO2003087092A2 Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease
10/23/2003WO2003087065A1 Inhibitors of glycinamide ribonucleotide transformylase
10/23/2003WO2003086475A1 Conjugates comprising cancer cell specific ligands, a sugar and diagnostic agents, and uses thereof
10/23/2003WO2003086448A1 Use of c5a receptor antagonist in the treatment of fibrosis
10/23/2003WO2003086326A2 G-type peptides to ameliorate atherosclerosis
10/23/2003WO2003086284A2 Colon tumor specific binding peptides
10/23/2003WO2003032902A3 Tumor targeted photodiagnostic-phototherapeutic agents
10/23/2003WO2002099099A3 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications
10/23/2003WO2002081505A3 Peptide for the diagnosis and therapy of alzheimer's disease
10/23/2003WO2001079267A9 A glycopeptide and preparation thereof
10/23/2003US20030200555 For Alzheimer's disease diagnosis, treatment
10/23/2003US20030199677 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
10/23/2003US20030199673 For inducing immune response and administering immunotherapy
10/23/2003US20030199671 For protein isolation and purification
10/23/2003US20030199434 Proliferation of chondrocytes to increase the biosynthesis of collagen administering angiotensinogen, angiotensin I and II including analogues, fragments and analogues and type 2 receptor agonists; amino acid sequences; kits
10/23/2003US20030199013 A preferred synthetic polypeptide having at least one antigenic site of a prion protein which only exist in nervous tissue of a mammal suffering from spongiform encephalopathy
10/23/2003US20030198644 HCV peptide antigens and methods for the determination of HCV
10/23/2003US20030198595 Completitive binding
10/23/2003CA2482926A1 Modified factor viii
10/23/2003CA2481996A1 Charge-balanced chemoselective linkers
10/23/2003CA2481895A1 Methods and reagents for assaying protein kinase activity
10/23/2003CA2481462A1 Heteroclitic analogs and related methods
10/23/2003CA2481344A1 Inhibitors of glycinamide ribonucleotide transformylase
10/23/2003CA2481231A1 Colon tumor specific binding peptides
10/23/2003CA2480217A1 G-type peptides to ameliorate atherosclerosis
10/22/2003EP1354894A2 Fusion peptide of human type-1 collagen derived peptide and tat peptide, preparation thereof, and skin anti-aging cosmetic composition comprising the same
10/22/2003EP1354033A2 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
10/22/2003EP1353683A2 Ghrelin analogs
10/22/2003EP1204676B1 Streptogramin derivatives, preparation and compositions containing same
10/22/2003EP1180121B1 Long lasting insulinotropic peptides
10/22/2003EP0922059B1 Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions
10/22/2003CN1451058A Continuous electrolytic pickling method for metallic products using alternate current suplied cells
10/22/2003CN1451017A Selective cyclic peptides
10/22/2003CN1451014A Peptidomimetic protease inhibitors
10/22/2003CN1451013A Nucleophile-stable thoester generating compounds, method of production and use
10/22/2003CN1450906A Methods and compositions for peptide synthesis
10/22/2003CN1125079C Cyclopeptolides
10/22/2003CN1125078C Active peptide
10/21/2003US6635752 Diagnosis of Aids
10/21/2003US6635740 Ligand/lytic peptide compositions and methods of use
10/21/2003US6635739 Non-mammalian GnRH analogs and uses thereof in regulation of fertility and pregnancy
10/21/2003US6635619 Amino acid sequence 88, 96, 97, 98, 99 or 100; increasing serum and tissue levels of active component
10/21/2003US6635417 Complex formation between DSDNA and oligomer of cyclic heterocycles
10/21/2003US6635265 Pesticidal polypeptide capable of inhibiting trypsin biosynthesis.
10/21/2003CA2053924C Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics
10/16/2003WO2003084985A1 Peptide chemically modified with polyethylene glycol
10/16/2003WO2003084980A2 Peptide amphiphile solutions and self assembled peptide nanofiber networks
10/16/2003WO2003084979A2 Novel peptides and the application thereof in therapy
10/16/2003WO2003084574A1 Multivalent constructs for therapeutic and diagnostic applications
10/16/2003WO2003084467A2 Epitope constructs comprising antigen presenting cell targeting mechanisms
10/16/2003WO2003033527A3 Cyclosporine analogue mixtures and their use as immunomodulating agents
10/16/2003WO2003016496A3 Zinc finger binding domains for cnn
10/16/2003WO2003012127A3 Assay for identifying inhibitors of hiv rt dimerization
10/16/2003WO2002057313A3 Receptor-binding compounds and methods for identifying them
10/16/2003WO2001034635A3 Methods and compositions for peptide synthesis
10/16/2003US20030195331 In situ chlorination, to generate amino acid chlorides, utilizing for solid phase peptide synthesis
10/16/2003US20030195158 Peptide derivatives
10/16/2003US20030195157 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
10/16/2003US20030195156 Tumor necrosis factors; cytokines; immunoglobulins; autoimmune diseases
10/16/2003US20030195152 Polymeric conjugates of antitumor agents
10/16/2003US20030195147 Identification of molecular structures, especially peptides, which are capable of acting at either insulin or insulin-like growth factor receptors as agonists or antagonists; treatment of diabetes
10/16/2003US20030195144 Antimicrobial compounds and formulations
10/16/2003US20030194743 Binding polypeptides for B lymphocyte stimulator protein (BLyS)
10/16/2003US20030194742 Diagnosis of tauopathies
10/16/2003US20030194729 Conantokins
10/16/2003US20030194712 Screening for target polypeptides that bind to RNA, using affinity purification methods, use of such target polypeptide for drug discovery and in methods of treating and preventing disease
10/16/2003US20030194408 Antibody which specifically binds to at least two variants of an epitope of an HIV-1 Tat protein
10/16/2003CA2481979A1 Peptides chemically modified with polyethylene glycol
10/16/2003CA2480996A1 Peptides derived or obtained from cytokine and the application thereof in therapy
10/16/2003CA2478930A1 Epitope constructs comprising antigen presenting cell targeting mechanisms
10/16/2003CA2477935A1 Multivalent constructs for therapeutic and diagnostic applications
10/15/2003EP1352911A1 Angiotensin converting enzyme inhibitors
10/15/2003EP1351992A2 Hybrid peptides for treatment of bacteremia and septicemia
10/15/2003EP1351977A1 Antimicrobial pseudopeptides
10/15/2003EP1351701A2 Active metabolite of antifungal compound
10/15/2003EP1351648A2 Carrier vectors through an epithelium with tight junctions
10/15/2003EP0912603B1 A process for preparing certain aza cyclohexapeptides
10/15/2003CN1449408A Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them
10/15/2003CN1449407A Molecule of pharmaceutical interest comprising at its n-terminal a glutamic acidor a glutamine in the form of physiologically acceptable
10/15/2003CN1124282C Conformationally constrained backbone cyclized somatostatin analogs
10/15/2003CN1124281C Somatostatin polypeptide analog and its application
10/14/2003US6632795 Treatment of cancer
10/14/2003US6632794 Insulin-like growth factor agonist molecules
10/14/2003US6632626 Cancer; anticarcinogenic agents; use of purified enzyme in screening protocols for the identification of possible anti-cancer agents which inhibit the enzyme and thereby prevent expression of the oncogenic ras proteins such as p21ras
10/14/2003US6632616 A peptide or polypeptide containing tryptophan and a charged amino acid selected from lysine, arganine and histidine and the compound is conjugated to a detactable group, useful to detect an expanded polyglutamine doamine in a sample
1 ... 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 ... 423